IL-15 renders conventional lymphocytes resistant to suppressive functions of regulatory T cells through activation of the phosphatidylinositol 3-kinase pathway

Journal of Immunology

Volumn 182, Issue 11, 2009, Pages 6763-6770

  Ahmed, Mélika Ben ^a,b,c   Hmida, Nadia Belhadj ^c   Moes, Nicolette ^a,b,d   Buyse, Sophie ^a,b   Abdeladhim, Maha ^c   Louzir, Hechmi ^c   Cerf Bensussan, Nadine ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 15; MONOCLONAL ANTIBODY CD28; MONOCLONAL ANTIBODY CD3; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; BIOSYNTHESIS; CELL CULTURE; CELL PROLIFERATION; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE; METABOLISM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-15; LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 67449168109     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0801792     Document Type: Article

References (48)

1. Fehniger, T. A., and M. A. Caligiuri. 2001. Interleukin 15: biology and relevance to human disease. Blood 97: 14-32.
2. Budagian, V., E. Bulanova, R. Paus, and S. Bulfone-Paus. 2006. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 17: 259-280.
3. Benahmed, M., B. Meresse, B. Arnulf, U. Barbe, J. J. Mention, V. Verkarre, M. Allez, C. Cellier, O. Hermine, and N. Cerf-Bensussan. 2007. Inhibition of TGF-β signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 132: 994-1008.
4. Aoki, C. A., A. T. Borchers, M. Li, R. A. Flavell, C. L. Bowlus, A. A. Ansari, and M. E. Gershwin. 2005. Transforming growth factor β (TGF-β) and autoimmunity. Autoimmun. Rev. 4: 450-459.
5. Yang, X., J. J. Letterio, R. J. Lechleider, L. Chen, R. Hayman, H. Gu, A. B. Roberts, and C. Deng. 1999. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J. 18: 1280-1291. (Pubitemid 29110312)
6. Waldmann, T. A., and Y. Tagaya. 1999. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol. 17: 19-49.
7. McInnes, I. B., and J. A. Gracie. 2004. Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. Curr. Opin. Pharmacol. 4: 392-397.
8. Letterio, J. J., and A. B. Roberts. 1998. Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 16: 137-161.
9. + T regulatory cells and TGF-β in mucosal immune system: the good and the bad. Curr. Med. Chem. 14: 2245-2249.
10. + regulatory T cells and immune tolerance. Autoimmunity 39: 269-276.
11. + Treg. Eur. J. Immunol. 38: 912-915.
12. + regulatory T cells. J. Exp. Med. 201: 1061-1067.
13. + T cells. J. Immunol. 173: 6526-6531.
14. Li, M. O., S. Sanjabi, and R. A. Flavell. 2006. Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25: 455-471.
15. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
16. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196: 237-246.
17. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194: 629-644.
18. + T cells. J. Exp. Med. 183: 2669-2674.
19. + regulatory T cells. J. Exp. Med. 201: 737-746.
20. You, S., B. Leforban, C. Garcia, J. F. Bach, J. A. Bluestone, and L. Chatenoud. 2007. Adaptive TGF-β-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. Proc. Natl. Acad. Sci. USA 104: 6335-6340.
21. + regulatory T cells is not essential for suppression of intestinal inflammation. Eur. J. Immunol. 35: 2886-2895.
22. - precursor cells in the absence of interleukin 10. Nat. Immunol. 8: 931-941.
23. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172: 5149-5153.
24. + regulatory T cells suppress Th1 mediated experimental colitis. Gut 55: 671-680.
25. + T lymphocytes. J. Immunol. 178: 732-739.
26. + regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease. J. Immunother. 29: 336-349.
27. + regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. Int. Immunol. 19: 785-799.
28. + regulatory T cells. J. Exp. Med. 201: 181-187.
29. Cantrell, D. 2002. Protein Kinase B (Akt) regulation and function in T lymphocytes. Semin. Immunol. 14: 19-26.
30. Ma, A., R. Koka, and P. Burkett. 2006. Diverse function of IL-2, IL-15 and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24: 657-679.
31. + T cells. Nat. Immunol. 8: 1353-1362.
32. Von Boehmer, H., and J. Nolting. 2008. What turns on Foxp3? Nat. Immunol. 9: 121-122.
33. - effector T cells. Int. Immunol. 20: 421-431.
34. + T regulatory cells. J. Immunol. 178: 4022-4026.
35. Shevach, E. M., D. Tran, Q. T. S. Davidson, and J. Andersson. 2008. The critical contribution of TGF-βto the induction of Foxp3 expression and regulatory T cell function. Eur. J. Immunol. 38: 915-917.
36. -T cells by T-cell receptor stimulation is transforming growth factor-β-dependent but does not confer a regulatory phenotype. Blood 110: 2983-2990.
37. Tone, Y., K. Furuuchi, Y. Kojima, M. L. Tykocinski, M. I. Greene, and M. Tone. 2008. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9: 194-202.
38. Wohlfert, E. A., and R. B. Clark. 2007. Vive la resistance!: the PI3K-Akt pathway can determine target sensitivity to regulatory T cell suppression. Trends Immunol. 28: 154-160.
39. + T lymphocytes. J. Immunol. 174: 155-163.
40. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151.
41. + regulatory T cells: independence of IL-2 consumption, TGF-β, and various inhibitors of TCR signaling. J. Immunol. 179: 3578-3587.
42. Vignali, D. 2008. How many mechanisms do regulatory T cells need? Eur. J. Immunol. 38: 908-911.
43. + regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9: 239-244.
44. + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. USA 105: 10113-10118.
45. Mohamadzadeh, M. F. Berard, G. Essert, C. Chalouni, B. Pulendran, J. Davoust, G. Bridges, Palucka and J. Banchereau. 2001. Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. 194: 1013-1020.
46. + T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
47. Nishimura, H., T. Yajima, Y. Naiki, H. Tsunobuchi, M. Umemura, K. Itano, T. Matsuguchi, M. Suzuki, P. S. Ohashi, and Y. Yoshikai. 2000. Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo. J. Exp. Med. 191: 157-170.
48. Mention, J. J., M. Ben Ahmed, B. Begue, U. Barbe, V. Verkarre, V. Asnafi, J. F. Colombel, P. H. Cugnenc, F. M. Ruemmele, E. McIntyre, et al. 2003. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125: 730-745.